NCT00004862 2013-02-01Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic LeukemiaNational Cancer Institute (NCI)Phase 1 Completed24 enrolled